FDA Drug Application (200435) for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number200435
Product Number001
FormTABLET;ORAL
Dosage5MG;12.5MG;160MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
Active IngredientAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by TEVA PHARMS